Zheng Quan Shi Bao Wang·2025-08-20 09:21Core Viewpoint - Lijun Group (000513) reported a slight decline in revenue for the first half of 2025, but achieved a notable increase in net profit, indicating a stable operational performance driven by various business segments [1] Financial Performance - The company achieved an operating revenue of 6.272 billion yuan, a year-on-year decrease of 0.17% [1] - The net profit attributable to shareholders reached 1.281 billion yuan, reflecting a year-on-year growth of 9.4% [1] - Basic earnings per share were reported at 1.43 yuan [1] Business Segments - The growth in the formulation segment contributed positively to the overall performance [1] - The high-margin specialty raw material drug exports in the raw material drug segment also played a significant role in profit increase [1]